166 related articles for article (PubMed ID: 19875064)
1. Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.
Fleming CJ; Andrews JC; Wiseman GA; Gansen DN; Roberts LR
J Vasc Interv Radiol; 2009 Nov; 20(11):1460-3. PubMed ID: 19875064
[TBL] [Abstract][Full Text] [Related]
2. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
[TBL] [Abstract][Full Text] [Related]
3. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):195-203. PubMed ID: 15713920
[TBL] [Abstract][Full Text] [Related]
4. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
Allison C
Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
[TBL] [Abstract][Full Text] [Related]
6. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
[TBL] [Abstract][Full Text] [Related]
7. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
[TBL] [Abstract][Full Text] [Related]
8. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma.
Liu MD; Uaje MB; Al-Ghazi MS; Fields D; Herman J; Kuo JV; Milne N; Nguyen TH; Ramsinghani NS; Tokita KM; Tsai FY; Vajgrt DJ; Imagawa DK
Am Surg; 2004 Nov; 70(11):947-53. PubMed ID: 15586503
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere).
Steel J; Baum A; Carr B
Psychooncology; 2004 Feb; 13(2):73-9. PubMed ID: 14872525
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
Kulik LM; Atassi B; van Holsbeeck L; Souman T; Lewandowski RJ; Mulcahy MF; Hunter RD; Nemcek AA; Abecassis MM; Haines KG; Salem R
J Surg Oncol; 2006 Dec; 94(7):572-86. PubMed ID: 17048240
[TBL] [Abstract][Full Text] [Related]
11. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
[TBL] [Abstract][Full Text] [Related]
12. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187
[TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
Salem R; Hunter RD
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.
Carr BI
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S107-10. PubMed ID: 14762849
[TBL] [Abstract][Full Text] [Related]
15. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
16. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
17. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.
Zeng ZC; Fan J; Tang ZY; Zhou J; Qin LX; Wang JH; Sun HC; Wang BL; Zhang JY; Jiang GL; Wang YQ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):432-43. PubMed ID: 15667964
[TBL] [Abstract][Full Text] [Related]
18. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
Salem R; Parikh P; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Ibrahim S; Mulcahy MF; Kulik L; Liu DM; Riaz A; Omary RA; Kennedy AS
Am J Clin Oncol; 2008 Oct; 31(5):431-8. PubMed ID: 18838878
[TBL] [Abstract][Full Text] [Related]
19. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
[TBL] [Abstract][Full Text] [Related]
20. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
Salem R; Lewandowski R; Roberts C; Goin J; Thurston K; Abouljoud M; Courtney A
J Vasc Interv Radiol; 2004 Apr; 15(4):335-45. PubMed ID: 15064336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
